Literature DB >> 27457793

The role of exclusive enteral nutrition in the management of orofacial granulomatosis in children.

Mohamed Mutalib1, Khaled Bezanti2, Mamoun Elawad2, Fevronia Kiparissi2.   

Abstract

BACKGROUND: Orofacial granulomatosis (OFG) is a term used to describe a persistent, painless swelling of lips and orofacial region. It can be associated with ulceration, gingival hypertrophy and cobble stone appearance of the buccal mucosa. OFG is commonly associated with Crohn's disease and can precede the intestinal manifestation of the disease. Exclusive enteral nutrition (EEN) is a recognized treatment for induction of remission for Crohn's disease. The aim of this study was to review the use of EEN in the management of OFG in children.
METHODS: Retrospective review of medical records of all children diagnosed with OFG between 2007 and 2012 was conducted. Presence of comorbidities, progression to inflammatory bowel disease (IBD) and response to EEN was evaluated.
RESULTS: Twenty-nine children were included, mean age at diagnosis was 9 years (standard deviation 3.9) years. Ten children had isolated OFG and 19 had OFG and IBD, of which 12 presented with OFG and IBD and 7 developed IBD later. Median time to progression to IBD was 33 months (inter quartile range: 9.8-85.5). Twenty-two children completed 6 weeks of EEN, and 19 showed clinical improvement in the OFG appearance.
CONCLUSION: EEN appears to be an effective treatment option for children with isolated OFG or OFG and IBD.

Entities:  

Keywords:  gastroenterology; inflammation; inflammatory bowel disease; orofacial granulomatosis

Mesh:

Year:  2016        PMID: 27457793     DOI: 10.1007/s12519-016-0045-7

Source DB:  PubMed          Journal:  World J Pediatr            Impact factor:   2.764


  23 in total

1.  Elemental diet in the treatment of orofacial Crohn's disease.

Authors:  E A B Cameron; S J Middleton
Journal:  Gut       Date:  2003-01       Impact factor: 23.059

2.  Standard versus rapid food reintroduction after exclusive enteral nutritional therapy in paediatric Crohn's disease.

Authors:  Abi Faiman; Mohamed Mutalib; Alexander Moylan; Natalie Morgan; Daniel Crespi; Mark Furman; Ajmal Kader
Journal:  Eur J Gastroenterol Hepatol       Date:  2014-03       Impact factor: 2.566

3.  Subepithelial dendritic B cells in orofacial granulomatosis.

Authors:  Pritash Patel; Francesca Barone; Carlo Nunes; Laurent Boursier; Edward Odell; Michael Escudier; Stephen Challacombe; Jonathan Brostoff; Jo Spencer; Jeremy Sanderson
Journal:  Inflamm Bowel Dis       Date:  2010-06       Impact factor: 5.325

4.  Thalidomide in the treatment of refractory orofacial granulomatosis.

Authors:  K Eustace; J Clowry; B Kirby; A Lally
Journal:  Br J Dermatol       Date:  2014-08-04       Impact factor: 9.302

5.  Monosodium glutamate-related orofacial granulomatosis. Review and case report.

Authors:  A J Oliver; A M Rich; P C Reade; G A Varigos; B G Radden
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1991-05

Review 6.  Oral Crohn's disease: is it a separable disease from orofacial granulomatosis? A review.

Authors:  Andrew P Zbar; Shomron Ben-Horin; Marc Beer-Gabel; Rami Eliakim
Journal:  J Crohns Colitis       Date:  2011-08-09       Impact factor: 9.071

7.  Gingival manifestations of orofacial granulomatosis.

Authors:  Sílvia V Lourenço; Alice Z C Lobo; Paula Boggio; Fernando Fezzi; Alexandre Sebastião; Marcello Menta S Nico
Journal:  Arch Dermatol       Date:  2008-12

Review 8.  An update on granulomatous diseases of the oral tissues.

Authors:  Faizan Alawi
Journal:  Dent Clin North Am       Date:  2013-08-15

Review 9.  Orofacial granulomatosis: review on aetiology and pathogenesis.

Authors:  W M Tilakaratne; J Freysdottir; F Fortune
Journal:  J Oral Pathol Med       Date:  2008-04       Impact factor: 4.253

10.  Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease.

Authors:  F M Ruemmele; G Veres; K L Kolho; A Griffiths; A Levine; J C Escher; J Amil Dias; A Barabino; C P Braegger; J Bronsky; S Buderus; J Martín-de-Carpi; L De Ridder; U L Fagerberg; J P Hugot; J Kierkus; S Kolacek; S Koletzko; P Lionetti; E Miele; V M Navas López; A Paerregaard; R K Russell; D E Serban; R Shaoul; P Van Rheenen; G Veereman; B Weiss; D Wilson; A Dignass; A Eliakim; H Winter; D Turner
Journal:  J Crohns Colitis       Date:  2014-06-06       Impact factor: 10.020

View more
  2 in total

Review 1.  British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults.

Authors:  Christopher Andrew Lamb; Nicholas A Kennedy; Tim Raine; Philip Anthony Hendy; Philip J Smith; Jimmy K Limdi; Bu'Hussain Hayee; Miranda C E Lomer; Gareth C Parkes; Christian Selinger; Kevin J Barrett; R Justin Davies; Cathy Bennett; Stuart Gittens; Malcolm G Dunlop; Omar Faiz; Aileen Fraser; Vikki Garrick; Paul D Johnston; Miles Parkes; Jeremy Sanderson; Helen Terry; Daniel R Gaya; Tariq H Iqbal; Stuart A Taylor; Melissa Smith; Matthew Brookes; Richard Hansen; A Barney Hawthorne
Journal:  Gut       Date:  2019-09-27       Impact factor: 23.059

2.  An overview of the role of exclusive enteral nutrition for complicated Crohn's disease.

Authors:  Mustafa Adamji; Andrew S Day
Journal:  Intest Res       Date:  2018-12-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.